104 related articles for article (PubMed ID: 10228616)
1. Assessment of liver and kidney enhancement with a perfluorocarbon vapor-stabilized US contrast agent.
Girard MS; Baker KG; Steinbach GC; Deiranieh LH; Peterson TM; Mattrey RF
Acad Radiol; 1999 May; 6(5):273-81. PubMed ID: 10228616
[TBL] [Abstract][Full Text] [Related]
2. Gray-scale liver enhancement in VX2 tumor-bearing rabbits using BR14, a new ultrasonographic contrast agent.
Schneider M; Broillet A; Bussat P; Giessinger N; Puginier J; Ventrone R; Yan F
Invest Radiol; 1997 Jul; 32(7):410-7. PubMed ID: 9228607
[TBL] [Abstract][Full Text] [Related]
3. B-mode enhancement of the liver with microbubble contrast agent: a blinded study in rabbits with VX2 tumors.
Girard MS; Kono Y; Sirlin CB; Baker KG; Deiranieh LH; Mattrey RF
Acad Radiol; 2001 Aug; 8(8):734-40. PubMed ID: 11508752
[TBL] [Abstract][Full Text] [Related]
4. Detection of hepatic VX2 tumors in rabbits: comparison of conventional US and phase-inversion harmonic US during the liver-specific late phase of contrast enhancement.
Lee JM; Youk JH; Lee YH; Kim YK; Kim CS; Li CA
Korean J Radiol; 2003; 4(2):124-9. PubMed ID: 12845308
[TBL] [Abstract][Full Text] [Related]
5. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
6. Radio-frequency-induced coagulation necrosis in rabbits: immediate detection at US with a synthetic microsphere contrast agent.
Goldberg SN; Walovitch RC; Straub JA; Shore MT; Gazelle GS
Radiology; 1999 Nov; 213(2):438-44. PubMed ID: 10551224
[TBL] [Abstract][Full Text] [Related]
7. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material.
Mattrey RF; Scheible FW; Gosink BB; Leopold GR; Long DM; Higgins CB
Radiology; 1982 Dec; 145(3):759-62. PubMed ID: 7146409
[TBL] [Abstract][Full Text] [Related]
8. Time-intensity-based quantification of vascularity with single-level dynamic contrast-enhanced ultrasonography: a pilot animal study.
Li J; Dong BW; Yu XL; Wang XH; Li CF
J Ultrasound Med; 2005 Jul; 24(7):975-83. PubMed ID: 15972712
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the iodine-free computed tomography liver contrast agent, Dy-EOB-DTPA, in comparison with a conventional iodinated agent in normal and in tumor-bearing rabbits.
Krause W; Handreke K; Schuhmann-Giampieri G; Rupp K
Invest Radiol; 2002 May; 37(5):241-7. PubMed ID: 11979149
[TBL] [Abstract][Full Text] [Related]
10. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
11. Parenchymal enhancement and tumor visualization using a new sonographic contrast agent.
Forsberg F; Liu JB; Merton DA; Rawool NM; Goldberg BB
J Ultrasound Med; 1995 Dec; 14(12):949-57. PubMed ID: 8583531
[TBL] [Abstract][Full Text] [Related]
12. Characterization of focal hepatic lesions in cirrhotic patients by Pulse Inversion Harmonic Imaging US contrast specific technique with Levovist.
Quaia E; Forgács B; Calderan L; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2002 Oct; 104(4):285-94. PubMed ID: 12569309
[TBL] [Abstract][Full Text] [Related]
13. Ablation of high intensity focused ultrasound combined with SonoVue on rabbit VX2 liver tumors: assessment with conventional gray-scale US, conventional color/power Doppler US, contrast-enhanced color Doppler US, and contrast-enhanced pulse-inversion harmonic US.
Luo W; Zhou X; He G; Li Q; Zheng X; Fan Z; Liu Q; Yu M; Han Z; Zhang J; Qian Y
Ann Surg Oncol; 2008 Oct; 15(10):2943-53. PubMed ID: 18612702
[TBL] [Abstract][Full Text] [Related]
14. Placental enhancement with AF0145, a perfluorocarbon-stabilized microbubble sonographic contrast agent.
Mattrey RF; Baker KG; Hall LA; Steinbach GC; Peterson T
Acad Radiol; 1996 Aug; 3 Suppl 2():S320-1. PubMed ID: 8796592
[No Abstract] [Full Text] [Related]
15. Stress Test of Contrast-Enhanced US with Phenylephrine in a Rabbit VX2 Liver Tumor Model: Differentiating Benign Periablational Enhancement from Residual Tumor after Radiofrequency Ablation.
Kan X; Zhang Y; Zheng C; Li L; Chen J; Wu Y; Guo T; Xiong B
J Vasc Interv Radiol; 2016 Jul; 27(7):1077-1085.e2. PubMed ID: 27117950
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different perfluorocarbons as ultrasound contrast agents.
Satterfield R; Tarter VM; Schumacher DJ; Tran P; Mattrey RF
Invest Radiol; 1993 Apr; 28(4):325-31. PubMed ID: 8478173
[TBL] [Abstract][Full Text] [Related]
17. Focal Nodular Hyperplasia of the Liver: Contrast-Enhanced Ultrasonographic Features With Sonazoid.
Lee J; Jeong WK; Lim HK; Kim AY
J Ultrasound Med; 2018 Jun; 37(6):1473-1480. PubMed ID: 29159819
[TBL] [Abstract][Full Text] [Related]
18. Comparison of standard and second harmonic B-mode sonography in the detection of segmental renal infarction with sonographic contrast in a rabbit model.
Girard MS; Mattrey RF; Baker KG; Peterson T; Deiranieh LH; Steinbach GC
J Ultrasound Med; 2000 Mar; 19(3):185-92; quiz 193. PubMed ID: 10709834
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-guided percutaneous laser and ethanol ablation of rabbit VX2 liver tumors.
Zou X; Liu Q; Zhou X; He G; Yu M; Han Z; Meng X; Su H
Acta Radiol; 2013 Mar; 54(2):181-7. PubMed ID: 23482351
[TBL] [Abstract][Full Text] [Related]
20. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
